Agios Pharmaceuticals AGIO Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's accrued manufacturing costs?
- Agios Pharmaceuticals (AGIO) reported accrued manufacturing costs of $11.69M in Q1 2026.
- How has Agios Pharmaceuticals's accrued manufacturing costs changed year-over-year?
- Agios Pharmaceuticals's accrued manufacturing costs increased by 49.8% year-over-year, from $7.8M to $11.69M.
- What is the long-term trend for Agios Pharmaceuticals's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's accrued manufacturing costs has grown at a 6.0% compound annual growth rate (CAGR), from $20.35M to $27.26M.